Global Meloxicam Drug Market Insights, Forecast to 2034
Meloxicam (Mobic) is used to treat pain or inflammation caused by osteoarthritis or rheumatoid arthritis.
Global Meloxicam Drug market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Meloxicam Drug industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Meloxicam Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Meloxicam Drug market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Boehringer-Ingelheim
TerSera Therapeutics
Iroko Pharmaceuticals
Apotex
Yung Shin Pharmaceutical
Breckenridge Pharmaceutical
Zydus Pharmaceuticals
Unichem Pharmaceuticals
Strides Pharma
Cipla
Dr. Reddy's Laboratories
Glenmark Pharmaceuticals
Teva
PuraCap Pharmaceutical
TARO
Lupin Pharmaceuticals
Aurobindo Pharma
Segment by Type
Tablet
Capsule
Segment by Application
Osteoarthritis in Adults (OA)
Rheumatoid Arthritis in Adults (RA)
Pediatric Patients
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Meloxicam Drug plant distribution, commercial date of Meloxicam Drug, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Meloxicam Drug introduction, etc. Meloxicam Drug Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Meloxicam Drug
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Table of Content
1 Study Coverage
1.1 Meloxicam Drug Product Introduction
1.2 Market by Type
1.2.1 Global Meloxicam Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Tablet
1.2.3 Capsule
1.3 Market by Application
1.3.1 Global Meloxicam Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Osteoarthritis in Adults (OA)
1.3.3 Rheumatoid Arthritis in Adults (RA)
1.3.4 Pediatric Patients
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Meloxicam Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Meloxicam Drug Revenue by Region
2.2.1 Global Meloxicam Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Meloxicam Drug Revenue by Region (2018-2024)
2.2.3 Global Meloxicam Drug Revenue by Region (2024-2029)
2.2.4 Global Meloxicam Drug Revenue Market Share by Region (2018-2029)
2.3 Global Meloxicam Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Meloxicam Drug Sales by Region
2.4.1 Global Meloxicam Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Meloxicam Drug Sales by Region (2018-2024)
2.4.3 Global Meloxicam Drug Sales by Region (2024-2029)
2.4.4 Global Meloxicam Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Meloxicam Drug Sales by Manufacturers
3.1.1 Global Meloxicam Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Meloxicam Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Meloxicam Drug in 2022
3.2 Global Meloxicam Drug Revenue by Manufacturers
3.2.1 Global Meloxicam Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Meloxicam Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Meloxicam Drug Revenue in 2022
3.3 Global Key Players of Meloxicam Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Meloxicam Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Meloxicam Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Meloxicam Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Meloxicam Drug, Product Offered and Application
3.8 Global Key Manufacturers of Meloxicam Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Meloxicam Drug Sales by Type
4.1.1 Global Meloxicam Drug Historical Sales by Type (2018-2024)
4.1.2 Global Meloxicam Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Meloxicam Drug Sales Market Share by Type (2018-2029)
4.2 Global Meloxicam Drug Revenue by Type
4.2.1 Global Meloxicam Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Meloxicam Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Meloxicam Drug Revenue Market Share by Type (2018-2029)
4.3 Global Meloxicam Drug Price by Type
4.3.1 Global Meloxicam Drug Price by Type (2018-2024)
4.3.2 Global Meloxicam Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Meloxicam Drug Sales by Application
5.1.1 Global Meloxicam Drug Historical Sales by Application (2018-2024)
5.1.2 Global Meloxicam Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Meloxicam Drug Sales Market Share by Application (2018-2029)
5.2 Global Meloxicam Drug Revenue by Application
5.2.1 Global Meloxicam Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Meloxicam Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Meloxicam Drug Revenue Market Share by Application (2018-2029)
5.3 Global Meloxicam Drug Price by Application
5.3.1 Global Meloxicam Drug Price by Application (2018-2024)
5.3.2 Global Meloxicam Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Meloxicam Drug Market Size by Type
6.1.1 US & Canada Meloxicam Drug Sales by Type (2018-2029)
6.1.2 US & Canada Meloxicam Drug Revenue by Type (2018-2029)
6.2 US & Canada Meloxicam Drug Market Size by Application
6.2.1 US & Canada Meloxicam Drug Sales by Application (2018-2029)
6.2.2 US & Canada Meloxicam Drug Revenue by Application (2018-2029)
6.3 US & Canada Meloxicam Drug Market Size by Country
6.3.1 US & Canada Meloxicam Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Meloxicam Drug Sales by Country (2018-2029)
6.3.3 US & Canada Meloxicam Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Meloxicam Drug Market Size by Type
7.1.1 Europe Meloxicam Drug Sales by Type (2018-2029)
7.1.2 Europe Meloxicam Drug Revenue by Type (2018-2029)
7.2 Europe Meloxicam Drug Market Size by Application
7.2.1 Europe Meloxicam Drug Sales by Application (2018-2029)
7.2.2 Europe Meloxicam Drug Revenue by Application (2018-2029)
7.3 Europe Meloxicam Drug Market Size by Country
7.3.1 Europe Meloxicam Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Meloxicam Drug Sales by Country (2018-2029)
7.3.3 Europe Meloxicam Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Meloxicam Drug Market Size
8.1.1 China Meloxicam Drug Sales (2018-2029)
8.1.2 China Meloxicam Drug Revenue (2018-2029)
8.2 China Meloxicam Drug Market Size by Application
8.2.1 China Meloxicam Drug Sales by Application (2018-2029)
8.2.2 China Meloxicam Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Meloxicam Drug Market Size by Type
9.1.1 Asia Meloxicam Drug Sales by Type (2018-2029)
9.1.2 Asia Meloxicam Drug Revenue by Type (2018-2029)
9.2 Asia Meloxicam Drug Market Size by Application
9.2.1 Asia Meloxicam Drug Sales by Application (2018-2029)
9.2.2 Asia Meloxicam Drug Revenue by Application (2018-2029)
9.3 Asia Meloxicam Drug Sales by Region
9.3.1 Asia Meloxicam Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Meloxicam Drug Revenue by Region (2018-2029)
9.3.3 Asia Meloxicam Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Meloxicam Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Meloxicam Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Meloxicam Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Meloxicam Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Meloxicam Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Meloxicam Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Meloxicam Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Meloxicam Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Meloxicam Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Meloxicam Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Boehringer-Ingelheim
11.1.1 Boehringer-Ingelheim Company Information
11.1.2 Boehringer-Ingelheim Overview
11.1.3 Boehringer-Ingelheim Meloxicam Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Boehringer-Ingelheim Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Boehringer-Ingelheim Recent Developments
11.2 TerSera Therapeutics
11.2.1 TerSera Therapeutics Company Information
11.2.2 TerSera Therapeutics Overview
11.2.3 TerSera Therapeutics Meloxicam Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 TerSera Therapeutics Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 TerSera Therapeutics Recent Developments
11.3 Iroko Pharmaceuticals
11.3.1 Iroko Pharmaceuticals Company Information
11.3.2 Iroko Pharmaceuticals Overview
11.3.3 Iroko Pharmaceuticals Meloxicam Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Iroko Pharmaceuticals Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Iroko Pharmaceuticals Recent Developments
11.4 Apotex
11.4.1 Apotex Company Information
11.4.2 Apotex Overview
11.4.3 Apotex Meloxicam Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Apotex Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Apotex Recent Developments
11.5 Yung Shin Pharmaceutical
11.5.1 Yung Shin Pharmaceutical Company Information
11.5.2 Yung Shin Pharmaceutical Overview
11.5.3 Yung Shin Pharmaceutical Meloxicam Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Yung Shin Pharmaceutical Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Yung Shin Pharmaceutical Recent Developments
11.6 Breckenridge Pharmaceutical
11.6.1 Breckenridge Pharmaceutical Company Information
11.6.2 Breckenridge Pharmaceutical Overview
11.6.3 Breckenridge Pharmaceutical Meloxicam Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Breckenridge Pharmaceutical Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Breckenridge Pharmaceutical Recent Developments
11.7 Zydus Pharmaceuticals
11.7.1 Zydus Pharmaceuticals Company Information
11.7.2 Zydus Pharmaceuticals Overview
11.7.3 Zydus Pharmaceuticals Meloxicam Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Zydus Pharmaceuticals Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Zydus Pharmaceuticals Recent Developments
11.8 Unichem Pharmaceuticals
11.8.1 Unichem Pharmaceuticals Company Information
11.8.2 Unichem Pharmaceuticals Overview
11.8.3 Unichem Pharmaceuticals Meloxicam Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Unichem Pharmaceuticals Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Unichem Pharmaceuticals Recent Developments
11.9 Strides Pharma
11.9.1 Strides Pharma Company Information
11.9.2 Strides Pharma Overview
11.9.3 Strides Pharma Meloxicam Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Strides Pharma Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Strides Pharma Recent Developments
11.10 Cipla
11.10.1 Cipla Company Information
11.10.2 Cipla Overview
11.10.3 Cipla Meloxicam Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Cipla Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Cipla Recent Developments
11.11 Dr. Reddy's Laboratories
11.11.1 Dr. Reddy's Laboratories Company Information
11.11.2 Dr. Reddy's Laboratories Overview
11.11.3 Dr. Reddy's Laboratories Meloxicam Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Dr. Reddy's Laboratories Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Dr. Reddy's Laboratories Recent Developments
11.12 Glenmark Pharmaceuticals
11.12.1 Glenmark Pharmaceuticals Company Information
11.12.2 Glenmark Pharmaceuticals Overview
11.12.3 Glenmark Pharmaceuticals Meloxicam Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Glenmark Pharmaceuticals Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Glenmark Pharmaceuticals Recent Developments
11.13 Teva
11.13.1 Teva Company Information
11.13.2 Teva Overview
11.13.3 Teva Meloxicam Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Teva Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Teva Recent Developments
11.14 PuraCap Pharmaceutical
11.14.1 PuraCap Pharmaceutical Company Information
11.14.2 PuraCap Pharmaceutical Overview
11.14.3 PuraCap Pharmaceutical Meloxicam Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 PuraCap Pharmaceutical Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 PuraCap Pharmaceutical Recent Developments
11.15 TARO
11.15.1 TARO Company Information
11.15.2 TARO Overview
11.15.3 TARO Meloxicam Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 TARO Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 TARO Recent Developments
11.16 Lupin Pharmaceuticals
11.16.1 Lupin Pharmaceuticals Company Information
11.16.2 Lupin Pharmaceuticals Overview
11.16.3 Lupin Pharmaceuticals Meloxicam Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Lupin Pharmaceuticals Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Lupin Pharmaceuticals Recent Developments
11.17 Aurobindo Pharma
11.17.1 Aurobindo Pharma Company Information
11.17.2 Aurobindo Pharma Overview
11.17.3 Aurobindo Pharma Meloxicam Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Aurobindo Pharma Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Aurobindo Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Meloxicam Drug Industry Chain Analysis
12.2 Meloxicam Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Meloxicam Drug Production Mode & Process
12.4 Meloxicam Drug Sales and Marketing
12.4.1 Meloxicam Drug Sales Channels
12.4.2 Meloxicam Drug Distributors
12.5 Meloxicam Drug Customers
13 Market Dynamics
13.1 Meloxicam Drug Industry Trends
13.2 Meloxicam Drug Market Drivers
13.3 Meloxicam Drug Market Challenges
13.4 Meloxicam Drug Market Restraints
14 Key Findings in The Global Meloxicam Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Figure
List of Tables
Table 1. Global Meloxicam Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Tablet
Table 3. Major Manufacturers of Capsule
Table 4. Global Meloxicam Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Meloxicam Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Meloxicam Drug Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Meloxicam Drug Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Meloxicam Drug Revenue Market Share by Region (2018-2024)
Table 9. Global Meloxicam Drug Revenue Market Share by Region (2024-2029)
Table 10. Global Meloxicam Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Meloxicam Drug Sales by Region (2018-2024) & (K Units)
Table 12. Global Meloxicam Drug Sales by Region (2024-2029) & (K Units)
Table 13. Global Meloxicam Drug Sales Market Share by Region (2018-2024)
Table 14. Global Meloxicam Drug Sales Market Share by Region (2024-2029)
Table 15. Global Meloxicam Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Meloxicam Drug Sales Share by Manufacturers (2018-2024)
Table 17. Global Meloxicam Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Meloxicam Drug Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Meloxicam Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Meloxicam Drug Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Meloxicam Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Meloxicam Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meloxicam Drug as of 2022)
Table 23. Global Key Manufacturers of Meloxicam Drug, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Meloxicam Drug, Product Offered and Application
Table 25. Global Key Manufacturers of Meloxicam Drug, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Meloxicam Drug Sales by Type (2018-2024) & (K Units)
Table 28. Global Meloxicam Drug Sales by Type (2024-2029) & (K Units)
Table 29. Global Meloxicam Drug Sales Share by Type (2018-2024)
Table 30. Global Meloxicam Drug Sales Share by Type (2024-2029)
Table 31. Global Meloxicam Drug Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Meloxicam Drug Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Meloxicam Drug Revenue Share by Type (2018-2024)
Table 34. Global Meloxicam Drug Revenue Share by Type (2024-2029)
Table 35. Meloxicam Drug Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Meloxicam Drug Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Meloxicam Drug Sales by Application (2018-2024) & (K Units)
Table 38. Global Meloxicam Drug Sales by Application (2024-2029) & (K Units)
Table 39. Global Meloxicam Drug Sales Share by Application (2018-2024)
Table 40. Global Meloxicam Drug Sales Share by Application (2024-2029)
Table 41. Global Meloxicam Drug Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Meloxicam Drug Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Meloxicam Drug Revenue Share by Application (2018-2024)
Table 44. Global Meloxicam Drug Revenue Share by Application (2024-2029)
Table 45. Meloxicam Drug Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Meloxicam Drug Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Meloxicam Drug Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Meloxicam Drug Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Meloxicam Drug Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Meloxicam Drug Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Meloxicam Drug Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Meloxicam Drug Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Meloxicam Drug Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Meloxicam Drug Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Meloxicam Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Meloxicam Drug Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Meloxicam Drug Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Meloxicam Drug Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Meloxicam Drug Sales by Country (2024-2029) & (K Units)
Table 60. Europe Meloxicam Drug Sales by Type (2018-2024) & (K Units)
Table 61. Europe Meloxicam Drug Sales by Type (2024-2029) & (K Units)
Table 62. Europe Meloxicam Drug Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Meloxicam Drug Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Meloxicam Drug Sales by Application (2018-2024) & (K Units)
Table 65. Europe Meloxicam Drug Sales by Application (2024-2029) & (K Units)
Table 66. Europe Meloxicam Drug Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Meloxicam Drug Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Meloxicam Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Meloxicam Drug Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Meloxicam Drug Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Meloxicam Drug Sales by Country (2018-2024) & (K Units)
Table 72. Europe Meloxicam Drug Sales by Country (2024-2029) & (K Units)
Table 73. China Meloxicam Drug Sales by Type (2018-2024) & (K Units)
Table 74. China Meloxicam Drug Sales by Type (2024-2029) & (K Units)
Table 75. China Meloxicam Drug Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Meloxicam Drug Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Meloxicam Drug Sales by Application (2018-2024) & (K Units)
Table 78. China Meloxicam Drug Sales by Application (2024-2029) & (K Units)
Table 79. China Meloxicam Drug Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Meloxicam Drug Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Meloxicam Drug Sales by Type (2018-2024) & (K Units)
Table 82. Asia Meloxicam Drug Sales by Type (2024-2029) & (K Units)
Table 83. Asia Meloxicam Drug Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Meloxicam Drug Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Meloxicam Drug Sales by Application (2018-2024) & (K Units)
Table 86. Asia Meloxicam Drug Sales by Application (2024-2029) & (K Units)
Table 87. Asia Meloxicam Drug Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Meloxicam Drug Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Meloxicam Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Meloxicam Drug Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Meloxicam Drug Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Meloxicam Drug Sales by Region (2018-2024) & (K Units)
Table 93. Asia Meloxicam Drug Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Meloxicam Drug Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Meloxicam Drug Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Meloxicam Drug Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Meloxicam Drug Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Meloxicam Drug Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Meloxicam Drug Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Meloxicam Drug Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Meloxicam Drug Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Meloxicam Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Meloxicam Drug Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Meloxicam Drug Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Meloxicam Drug Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Meloxicam Drug Sales by Country (2024-2029) & (K Units)
Table 107. Boehringer-Ingelheim Company Information
Table 108. Boehringer-Ingelheim Description and Major Businesses
Table 109. Boehringer-Ingelheim Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Boehringer-Ingelheim Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Boehringer-Ingelheim Recent Developments
Table 112. TerSera Therapeutics Company Information
Table 113. TerSera Therapeutics Description and Major Businesses
Table 114. TerSera Therapeutics Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. TerSera Therapeutics Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. TerSera Therapeutics Recent Developments
Table 117. Iroko Pharmaceuticals Company Information
Table 118. Iroko Pharmaceuticals Description and Major Businesses
Table 119. Iroko Pharmaceuticals Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Iroko Pharmaceuticals Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Iroko Pharmaceuticals Recent Developments
Table 122. Apotex Company Information
Table 123. Apotex Description and Major Businesses
Table 124. Apotex Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Apotex Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Apotex Recent Developments
Table 127. Yung Shin Pharmaceutical Company Information
Table 128. Yung Shin Pharmaceutical Description and Major Businesses
Table 129. Yung Shin Pharmaceutical Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Yung Shin Pharmaceutical Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Yung Shin Pharmaceutical Recent Developments
Table 132. Breckenridge Pharmaceutical Company Information
Table 133. Breckenridge Pharmaceutical Description and Major Businesses
Table 134. Breckenridge Pharmaceutical Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Breckenridge Pharmaceutical Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Breckenridge Pharmaceutical Recent Developments
Table 137. Zydus Pharmaceuticals Company Information
Table 138. Zydus Pharmaceuticals Description and Major Businesses
Table 139. Zydus Pharmaceuticals Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Zydus Pharmaceuticals Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Zydus Pharmaceuticals Recent Developments
Table 142. Unichem Pharmaceuticals Company Information
Table 143. Unichem Pharmaceuticals Description and Major Businesses
Table 144. Unichem Pharmaceuticals Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Unichem Pharmaceuticals Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Unichem Pharmaceuticals Recent Developments
Table 147. Strides Pharma Company Information
Table 148. Strides Pharma Description and Major Businesses
Table 149. Strides Pharma Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Strides Pharma Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Strides Pharma Recent Developments
Table 152. Cipla Company Information
Table 153. Cipla Description and Major Businesses
Table 154. Cipla Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 155. Cipla Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Cipla Recent Developments
Table 157. Dr. Reddy's Laboratories Company Information
Table 158. Dr. Reddy's Laboratories Description and Major Businesses
Table 159. Dr. Reddy's Laboratories Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 160. Dr. Reddy's Laboratories Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Dr. Reddy's Laboratories Recent Developments
Table 162. Glenmark Pharmaceuticals Company Information
Table 163. Glenmark Pharmaceuticals Description and Major Businesses
Table 164. Glenmark Pharmaceuticals Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 165. Glenmark Pharmaceuticals Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Glenmark Pharmaceuticals Recent Developments
Table 167. Teva Company Information
Table 168. Teva Description and Major Businesses
Table 169. Teva Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 170. Teva Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Teva Recent Developments
Table 172. PuraCap Pharmaceutical Company Information
Table 173. PuraCap Pharmaceutical Description and Major Businesses
Table 174. PuraCap Pharmaceutical Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 175. PuraCap Pharmaceutical Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. PuraCap Pharmaceutical Recent Developments
Table 177. TARO Company Information
Table 178. TARO Description and Major Businesses
Table 179. TARO Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 180. TARO Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. TARO Recent Developments
Table 182. Lupin Pharmaceuticals Company Information
Table 183. Lupin Pharmaceuticals Description and Major Businesses
Table 184. Lupin Pharmaceuticals Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 185. Lupin Pharmaceuticals Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Lupin Pharmaceuticals Recent Developments
Table 187. Aurobindo Pharma Company Information
Table 188. Aurobindo Pharma Description and Major Businesses
Table 189. Aurobindo Pharma Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 190. Aurobindo Pharma Meloxicam Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Aurobindo Pharma Recent Developments
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Meloxicam Drug Distributors List
Table 195. Meloxicam Drug Customers List
Table 196. Meloxicam Drug Market Trends
Table 197. Meloxicam Drug Market Drivers
Table 198. Meloxicam Drug Market Challenges
Table 199. Meloxicam Drug Market Restraints
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Meloxicam Drug Product Picture
Figure 2. Global Meloxicam Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Meloxicam Drug Market Share by Type in 2022 & 2029
Figure 4. Tablet Product Picture
Figure 5. Capsule Product Picture
Figure 6. Global Meloxicam Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Meloxicam Drug Market Share by Application in 2022 & 2029
Figure 8. Osteoarthritis in Adults (OA)
Figure 9. Rheumatoid Arthritis in Adults (RA)
Figure 10. Pediatric Patients
Figure 11. Meloxicam Drug Report Years Considered
Figure 12. Global Meloxicam Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Meloxicam Drug Revenue 2018-2029 (US$ Million)
Figure 14. Global Meloxicam Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Meloxicam Drug Revenue Market Share by Region (2018-2029)
Figure 16. Global Meloxicam Drug Sales 2018-2029 ((K Units)
Figure 17. Global Meloxicam Drug Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Meloxicam Drug Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Meloxicam Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Meloxicam Drug Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Meloxicam Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Meloxicam Drug Sales YoY (2018-2029) & (K Units)
Figure 23. China Meloxicam Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Meloxicam Drug Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Meloxicam Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Meloxicam Drug Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Meloxicam Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Meloxicam Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Meloxicam Drug in the World: Market Share by Meloxicam Drug Revenue in 2022
Figure 30. Global Meloxicam Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Meloxicam Drug Sales Market Share by Type (2018-2029)
Figure 32. Global Meloxicam Drug Revenue Market Share by Type (2018-2029)
Figure 33. Global Meloxicam Drug Sales Market Share by Application (2018-2029)
Figure 34. Global Meloxicam Drug Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Meloxicam Drug Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Meloxicam Drug Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Meloxicam Drug Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Meloxicam Drug Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Meloxicam Drug Revenue Share by Country (2018-2029)
Figure 40. US & Canada Meloxicam Drug Sales Share by Country (2018-2029)
Figure 41. U.S. Meloxicam Drug Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Meloxicam Drug Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Meloxicam Drug Sales Market Share by Type (2018-2029)
Figure 44. Europe Meloxicam Drug Revenue Market Share by Type (2018-2029)
Figure 45. Europe Meloxicam Drug Sales Market Share by Application (2018-2029)
Figure 46. Europe Meloxicam Drug Revenue Market Share by Application (2018-2029)
Figure 47. Europe Meloxicam Drug Revenue Share by Country (2018-2029)
Figure 48. Europe Meloxicam Drug Sales Share by Country (2018-2029)
Figure 49. Germany Meloxicam Drug Revenue (2018-2029) & (US$ Million)
Figure 50. France Meloxicam Drug Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Meloxicam Drug Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Meloxicam Drug Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Meloxicam Drug Revenue (2018-2029) & (US$ Million)
Figure 54. China Meloxicam Drug Sales Market Share by Type (2018-2029)
Figure 55. China Meloxicam Drug Revenue Market Share by Type (2018-2029)
Figure 56. China Meloxicam Drug Sales Market Share by Application (2018-2029)
Figure 57. China Meloxicam Drug Revenue Market Share by Application (2018-2029)
Figure 58. Asia Meloxicam Drug Sales Market Share by Type (2018-2029)
Figure 59. Asia Meloxicam Drug Revenue Market Share by Type (2018-2029)
Figure 60. Asia Meloxicam Drug Sales Market Share by Application (2018-2029)
Figure 61. Asia Meloxicam Drug Revenue Market Share by Application (2018-2029)
Figure 62. Asia Meloxicam Drug Revenue Share by Region (2018-2029)
Figure 63. Asia Meloxicam Drug Sales Share by Region (2018-2029)
Figure 64. Japan Meloxicam Drug Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Meloxicam Drug Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Meloxicam Drug Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Meloxicam Drug Revenue (2018-2029) & (US$ Million)
Figure 68. India Meloxicam Drug Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Meloxicam Drug Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Meloxicam Drug Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Meloxicam Drug Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Meloxicam Drug Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Meloxicam Drug Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Meloxicam Drug Sales Share by Country (2018-2029)
Figure 75. Brazil Meloxicam Drug Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Meloxicam Drug Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Meloxicam Drug Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Meloxicam Drug Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Meloxicam Drug Revenue (2018-2029) & (US$ Million)
Figure 80. Meloxicam Drug Value Chain
Figure 81. Meloxicam Drug Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices